Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
September 30, 2025 18.32M
September 30, 2024 25.66M
September 30, 2023 9.626M
September 30, 2022 80.19M
September 30, 2021 122.36M
September 30, 2020 13.59M
September 30, 2019 6.295M
September 30, 2018 3.760M
September 30, 2017 3.278M
September 30, 2016 2.385M
September 30, 2015 4.106M
September 30, 2014 5.796M
September 30, 2013 8.922M
September 30, 2012 5.296M
September 30, 2011 4.318M
September 30, 2010 2.923M
Date Value
September 30, 2009 2.915M
September 30, 2008 2.134M
September 30, 2007 0.8859M
September 30, 2006 2.065M
September 30, 2005 1.775M
September 30, 2004 0.7555M
September 30, 2003 0.752M
September 30, 2002 0.559M
September 30, 2001 0.469M
September 30, 2000 0.4571M
September 30, 1999 0.5707M
September 30, 1998 1.480M
September 30, 1997 1.634M
September 30, 1996 2.914M
September 30, 1995 1.521M
September 30, 1994 3.525M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 294.75M
Corcept Therapeutics, Inc. 372.15M
Johnson & Johnson 20.10B
Eli Lilly & Co. 7.268B
Lexicon Pharmaceuticals, Inc. 96.23M